PROGRAMME TUESDAY, 18.04.2017

>>> download the programme

13.30 – 14.30

COFFEE / REGISTRATION

14.30 – 15.00

OPENING AND WELCOME

Welcome word:

  • Eberhard Schatz, Correlation Network
  • Stephen Malloy, European Network of People Who Use Drugs
  • Denis Onyango, European African Treatment Advocates Network

 

  • Welcome address and EASL recommendations on the treatment of HCV
    Frank Tacke, European Association of the Study of the Liver
  • Hepatitis C elimination needs involving of all – turn the page
    Graham Foster, Queen Mary University of London

 

15.00 – 16.00

PLENARY SPEECHES: 

  • From data collection to recommendation – Philippa Easterbrook, Global Hepatitis Programme, WHO
  • From recommendation to practice: Access to testing and treatment in Europe – Mojca Maticic, Clinic for Infectious Disease and Febrile Illnesses, University Medical Centre Ljubljana
  • From peer to research – Magdalena Harris, London School of Hygiene and Tropical Medicine
  • From patient to advocate – Anton Basenko, International HIV/AIDS Alliance in Ukraine

 

16.00 – 16.30

COFFEE BREAK

 

16.30 – 17.15

ROUND TABLE DISCUSSION: EXPERIENCES TO TREAT RISK GROUPS IN A BARRIER FREE, LOW THRESHOLD SETTING

Moderator: Chris Ford, IDHDP

Speakers:

  • John Dillon, University of Dundee, Scotland
  • Vo Tran, GAIA, Paris
  • Hans Haltmayer, Suchthilfe, Vienna

 

17.15– 18.15

ROUND TABLE DISCUSSION: A POLITICIAN INTERVIEWS EXPERTS FROM DIFFERENT AREAS: ELIMINATION – CAN WE MAKE IT?

Moderator: Ricardo Baptista Leite, Member of Parliament, Portugal

  • Jason Grebely, The Kirby Institute, UNSW Sydney, from a research perspective
  • Daniel Simoes, EATG, from a community perspective
  • Celine Grillon, Medicine Du Monde, from an advocacy perspective
  • Maka Gogia, HR network Georgia about experiences on elimination in Georgia

 

18.30

RECEPTION

 


 

PROGRAMME WEDNESDAY, 19.04.2017

 

09.30 – 11.00

PLENARY SESSION:

  • Engaging Migrants – barriers to testing and treatment – Mesfin Ali, Embrace UK Community Support Centre, London
  • Thirty years of harm reduction in the Netherlands – HCV elimination ahead? – Esther Croes, Trimbos Institute, Utrecht
  • Hepatitis in prison settings – Heino Stöver, University of Applied Science, Frankfurt
  • Access in EECA countries – Natalia Kravchenko, Alliance for Public Health, Kiev

 

11.00 – 11.30

COFFEE BREAK

 

 11.30 – 13.00

PARALLEL SESSIONS

  • Parallel session 1 – The treatment cascadeGood practices from a diversity of countries on how HCV testing, outreach and treatment is organised in harm reduction settings
  • Parallel session 2 – Reach your crowdInnovative tools and methods for HCV awareness and information
  • Parallel session 3 – Workshop: On the moveInfectious diseases in migrant populations

>>> Session Details

13.00 – 14.30

LUNCH

 

13.00 – 14.30

LUNCH SESSION 1:

Path to Zero: Fresh thinking on the road to eliminating Hepatitis C

Lunchtime Session*: April 19, 2017, 1:00 – 2:30PM CEST

This session will bring together representatives from around the world to explore actionable ways to raise awareness of, finance initiatives to and put knowledge into practice to help eliminate HCV. The session will have a specific focus on the ‘Path to Zero’, a program developed by the Economist Intelligence Unit (EIU) and sponsored by AbbVie which aims to enhance awareness of and initiate a global dialogue around innovative solutions toward eliminating the disease. It will feature a panel discussion with ground-breaking innovators, or ‘HCV Change Makers’, to present case studies and explore new strategies to affect real change. The EIU will moderate the session, which is sponsored by AbbVie.

*Lunch will be provided.

 

13.00 – 14.30

LUNCH TIME SESSION 2: AIDS 2018:

How to give Hep C and harm reduction a better profile at AIDS2018! Brainstorm session on topics, speakers and other preparations for the international AIDS conference in Amsterdam next year.

Chair: Anke van Dam, AFEW

Please register for this session at: administration@correlation-net.org

 

 

14.30 – 16.00

PARRALEL SESSIONS

  • Parallel session 4 – Peer work is crucial
    Peer work has a key role in all phases of the process – prevention, testing and access to care
  • Parallel session 5 – Screening and monitoring
    Best practice examples in different areas of HCV counselling, screening and monitoring
  • Parallel session 6 – Availability and pricing
    Examples of effective advocacy for affordable DAA’s

>>> Session Details

 

16.00 – 16.30

COFFEE BREAK

 

16.30 – 17.30

PLENARY SESSION

The ELPA Hep Core Study results  – Jeff Lazarus, Rigshospitalet, University of Copenhagen and patients and community members with comments

Community Declaration
Presented by Magda Ferreira, peer worker at GAT, Portugal

 

18.00 – 20.00

FINAL NETWORKING SESSION, RECEPTION

  • WRAP UP video conference, prepared by Igor Kouzmenko, Drug User News, Kiev
  • Julian Hows, GNP+  – What can we learn from the HIV/AIDS movement?
  • Khalid Tinasti, Global Commission on Drugs presents the work of the Commission on Hepatitis and introduces the VIDEO message of Professor Michel Kazatchkine, former Executive director of the Global Fund to fight AIDS, tuberculosis and malaria
  • Ricardo Bapiste Leite, Member of National Parliament, Portugal presents Hepatitis C: Policy in Action!
 

 

12 + 5 =

Correlation Hepatitis C Initiative

tel. +31 20 570 7826 (direct)

c/o Foundation

De REGENBOOG GROEP

Droogbak 1d

1013 GE Amsterdam

The Netherlands

www.correlation-net.org

administration@correlation-net.org